The roles of PD-1/PD-L1 in the prognosis and immunotherapy of prostate cancer: Molecular Therapy
PD-L1 Neutralizing Antibody
FcγRs Modulate the Anti-tumor Activity of Antibodies Targeting the PD-1/PD- L1 Axis - ScienceDirect
TLR4 signaling improves PD-1 blockade therapy during chronic viral infection | PLOS Pathogens
Immunotherapy using anti-PD-1 and anti-PD-L1 in Leishmania amazonensis-infected BALB/c mice reduce parasite load | Scientific Reports
Frontiers | PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer | NEJM
Mouse PD-1 Antibody AF1021: R&D Systems
PD-1 Specific 'Blocking' Antibodies That Deplete PD-1+ T Cells Present An Inconvenient Variable In Pre-clinical Immunotherapy Experiments | bioRxiv
Study and analysis of antitumor resistance mechanism of PD1/PD‐L1 immune checkpoint blocker - Wang - 2020 - Cancer Medicine - Wiley Online Library
In Vitro Potency Assays for Assessing the Function of anti-PD-1 Checkpoint Inhibitors
InVivoMAb anti-mouse CTLA-4 (CD152, Clone: 9D9) | Bio X Cell
Frontiers | Combination Foretinib and Anti-PD-1 Antibody Immunotherapy for Colorectal Carcinoma
Anti-PD-1 Blocking Antibody Inhibits Human Melanoma Xenograft Growth in... | Download Scientific Diagram
Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo | Nature Biotechnology
Engineering high-affinity PD-1 variants for optimized immunotherapy and immuno-PET imaging | PNAS
JCM | Free Full-Text | Anti-PD-1 and Novel Combinations in the Treatment of Melanoma—An Update
A Brief Introduction to PD-1 Antibodies and Immunotherapy | ProSci Incorporated
Discovery of low-molecular weight anti-PD-L1 peptides for cancer immunotherapy | Journal for ImmunoTherapy of Cancer
PD-1/PD-L1 interaction blocked by antibodies, freeing T cell to kill tumor cell - FineTest ELISA Kit | FineTest Antibody | Wuhan Fine Biotech Co., Ltd.
The FG Loop of PD-1 Serves as a “Hotspot” for Therapeutic Monoclonal Antibodies in Tumor Immune Checkpoint Therapy - ScienceDirect
Release the B7.1! Anti-PD-L1 breaks PD-L1's grip
PD1 Antibody Selection Tool | Bio X Cell
Structural basis of HLX10 PD-1 receptor recognition, a promising anti-PD-1 antibody clinical candidate for cancer immunotherapy | PLOS ONE
PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1+CD38hi cells and anti-PD-1 resistance | Nature Immunology
A. C57BL/6 mice were intraperitoneally treated with an anti-PD-1... | Download Scientific Diagram
